nProblems
with the Amitryptyline & Cyclobenzaprine:
nSymptoms generally
improve after 1 month of treatment but
over time there efficacy decreases.
na study showed that 1 year after terminating the study’s end, 69% were still taking the medication
nThese same patients
actually reported increases in pain intensity,
fatigue, sleep difficulty, and global symptoms
despite the fact that continued taking the medication.
nSource:
Koopman: Arthritis & Allied Conditions, 1631
n